milrinone has been researched along with Insulin Sensitivity in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Milrinone is a widely-used phosphodiesterase III (PDE3)-selective inhibitor." | 1.32 | In vivo effects of phosphodiesterase III inhibitors on glucose metabolism and insulin sensitivity. ( Li, L; Yang, G, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mehanna, OM | 1 |
| El Askary, A | 1 |
| Al-Shehri, S | 1 |
| El-Esawy, B | 1 |
| Yang, G | 1 |
| Li, L | 1 |
2 other studies available for milrinone and Insulin Sensitivity
| Article | Year |
|---|---|
Effect of phosphodiesterase inhibitors on renal functions and oxidant/antioxidant parameters in streptozocin-induced diabetic rats.
Topics: Animals; Antioxidants; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Hyperglycemia; Hypog | 2018 |
In vivo effects of phosphodiesterase III inhibitors on glucose metabolism and insulin sensitivity.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type | 2003 |